Replies to post #12828 on NorthWest Biotherapeutics Inc (NWBO)

[Diamondjim61]

All good points Flip...

The opportunity is gaining ground and I think we will all have something to celebrate in the coming months.

And although I was contemplating selling my holdings on an ASCO run up (that never happened) and buying back in at the drop... I will hold until we get, what I think, will be a huge run up late this year or early next year.

GLTA.. thanks for all of your due diligence.

[Astavakra]

Share your view on what nobody likes to be told. Sometimes (more often than not, it seems), these vague or poorly chosen words and phrases do more harm than good. Plus, they are short on real substance. Like, 'a little bit.' Even if a little bit really means by 100 patients but she's hedging, it doesn't help to withhold that information. Ambiguity is sure to erode share price.

Speaking of which, I've been off the grid for a few days. Did Highwayman get a reply from LG?

[RRRichmond]

I viewed the several NWBO PRs and 10Qs and felt it was apparent that the trials had not yet started. I believe it was a point of discussion on this board that the HE would impact the planned trials at the various centers of excellence.

In the last 5 years I have invested in 6 bio-tech companies.(all speculative with phase 2 or 3 trials underway) Out of the 6, NWBO has been the most "to the point" in its PRs and its corporate communications. There are no wasted words or "pumping" of the stock by management. When LP chooses to defend the company it is well placed and again "to the point". She chooses to set the record straight and as the "ultimate long" defend the integrity of the company.

I view today's PR and the subsequent analysis from this board as evidence that "the shingle is hung" in Germany and now we can clearly see the implementation of the company's strategy unfolding.

Gentlemen, we have a product to sell and can now say we are in business in Germany.